GT200600162A - Metodos para modular la funcion de la vejiga - Google Patents
Metodos para modular la funcion de la vejigaInfo
- Publication number
- GT200600162A GT200600162A GT200600162A GT200600162A GT200600162A GT 200600162 A GT200600162 A GT 200600162A GT 200600162 A GT200600162 A GT 200600162A GT 200600162 A GT200600162 A GT 200600162A GT 200600162 A GT200600162 A GT 200600162A
- Authority
- GT
- Guatemala
- Prior art keywords
- bladder
- modulate
- function
- methods
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4433—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
ESTA INVENCIÓN POROPORCIONA MÉTODOS Y COMPOSICIONES FARMACÉUTICAS PARA MODULAR LA FUNCIÓN DE LA VEJIGA, Y EN PARTICULAR PARA MANTENER EL CONTROL DE LA VEJIGA O EL TRATAMIENTO DE LA INCONTINENCIA URINARIA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67448705P | 2005-04-24 | 2005-04-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200600162A true GT200600162A (es) | 2007-03-14 |
Family
ID=37056526
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200600162A GT200600162A (es) | 2005-04-24 | 2006-04-21 | Metodos para modular la funcion de la vejiga |
Country Status (11)
Country | Link |
---|---|
US (1) | US20060258712A1 (es) |
EP (1) | EP1874292A2 (es) |
JP (1) | JP2008538784A (es) |
CN (1) | CN101203217A (es) |
AU (1) | AU2006239941A1 (es) |
BR (1) | BRPI0609952A2 (es) |
CA (1) | CA2606064A1 (es) |
GT (1) | GT200600162A (es) |
MX (1) | MX2007013064A (es) |
TW (1) | TW200716106A (es) |
WO (1) | WO2006116169A2 (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6348486B1 (en) * | 2000-10-17 | 2002-02-19 | American Home Products Corporation | Methods for modulating bladder function |
GB0210397D0 (en) | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
US20050261347A1 (en) * | 2003-10-24 | 2005-11-24 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
US7435837B2 (en) * | 2003-10-24 | 2008-10-14 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
GT200500296A (es) * | 2004-10-21 | 2006-10-02 | Sintesis asimetrica de derivados del dehidrobenzofurano | |
GT200500297A (es) * | 2004-10-21 | 2006-10-27 | Sintesis asimetrica de dehidrobenzofuranos sustituidos | |
GT200600164A (es) * | 2005-04-22 | 2007-03-14 | Derivados de dihidrobenzofuranos y usos de los mismos | |
CA2605587A1 (en) * | 2005-04-22 | 2006-11-02 | Wyeth | Chromane and chromene derivatives and uses thereof |
TW200722081A (en) * | 2005-04-22 | 2007-06-16 | Wyeth Corp | New therapeutic combinations for the treatment or prevention of depression |
EP1879569A2 (en) * | 2005-04-22 | 2008-01-23 | Wyeth | Therapeutic combinations for the treatment or prevention of psychotic disorders |
JP2008538571A (ja) * | 2005-04-22 | 2008-10-30 | ワイス | ジヒドロベンゾフラン誘導体およびその使用 |
JP2008538575A (ja) * | 2005-04-22 | 2008-10-30 | ワイス | ベンゾジオキサンおよびベンゾジオキソラン誘導体ならびにそれらの使用 |
US20060258713A1 (en) * | 2005-04-22 | 2006-11-16 | Wyeth | Treatment of pain |
CN101203218A (zh) * | 2005-04-22 | 2008-06-18 | 惠氏公司 | 苯并呋喃基链烷胺衍生物和其作为5-ht2c激动剂的用途 |
CA2604759A1 (en) * | 2005-04-22 | 2006-11-02 | Wyeth | Dihydrobenzofuran derivatives and uses thereof |
AU2007230977A1 (en) * | 2006-03-24 | 2007-10-04 | Wyeth | Methods for treating cognitive and other disorders |
WO2007132841A1 (ja) | 2006-05-16 | 2007-11-22 | Takeda Pharmaceutical Company Limited | 縮合複素環化合物およびその用途 |
CA2988753A1 (en) | 2007-08-06 | 2009-02-12 | Serenity Pharmaceuticals, Llc | Methods and devices for desmopressin drug delivery |
WO2009063992A1 (ja) | 2007-11-15 | 2009-05-22 | Takeda Pharmaceutical Company Limited | 縮合ピリジン誘導体およびその用途 |
LT2712622T (lt) | 2008-05-21 | 2016-09-26 | Ferring B.V. | Burnoje disperguojamas desmopresinas, skirtas nikturijos netrikdomo miego pirminio periodo pailginimui |
US11963995B2 (en) | 2008-05-21 | 2024-04-23 | Ferring B.V. | Methods comprising desmopressin |
US20100286045A1 (en) | 2008-05-21 | 2010-11-11 | Bjarke Mirner Klein | Methods comprising desmopressin |
JPWO2019131902A1 (ja) | 2017-12-27 | 2020-12-10 | 武田薬品工業株式会社 | 腹圧性尿失禁および便失禁の治療薬 |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0166088B1 (ko) * | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
US5376645A (en) * | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
DE4200259A1 (de) * | 1992-01-08 | 1993-07-15 | Asta Medica Ag | Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung |
DK1221440T3 (da) * | 1994-06-15 | 2007-09-17 | Otsuka Pharma Co Ltd | Benzoheterocykliske derivater der er nyttige som vasopressin- eller oxytocinmodulatorer |
US5565483A (en) * | 1995-06-07 | 1996-10-15 | Bristol-Myers Squibb Company | 3-substituted oxindole derivatives as potassium channel modulators |
TW359669B (en) * | 1995-12-15 | 1999-06-01 | Otsuka Pharma Co Ltd | Benzazepine derivatives |
GB9711643D0 (en) * | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
US6194407B1 (en) * | 1997-07-30 | 2001-02-27 | American Home Products Corporation | Tricyclic pyrido vasopressin agonists |
US6090803A (en) * | 1998-07-24 | 2000-07-18 | American Home Products Corporation | Tricyclic vasopressin agonists |
AR033095A1 (es) * | 2001-04-04 | 2003-12-03 | Wyeth Corp | Metodos para el tratamiento de motilidad gastrica hiperactiva |
GB0207104D0 (en) * | 2002-03-26 | 2002-05-08 | Pfizer Ltd | Stable hydrate of a muscarinic receptor antagonist |
CL2004000826A1 (es) * | 2003-04-25 | 2005-03-04 | Pfizer | Uso de un agonista para el receptor 5-ht2c para preparar un medicamento util en el tratamiento de la incontinencia urinaria provocada por estres, con la condicion de que el agonista no sea 1-[6-cloro-5-(trifluorometil)-2-piridinil]piperazina (org-129 |
US20040235856A1 (en) * | 2003-04-25 | 2004-11-25 | Pfizer Inc | Treatment of incontinence |
US7435837B2 (en) * | 2003-10-24 | 2008-10-14 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
US7728155B2 (en) * | 2003-10-24 | 2010-06-01 | Wyeth Llc | Dihydrobenzofuranyl alkanamines and methods for using same as cns agents |
US20050261347A1 (en) * | 2003-10-24 | 2005-11-24 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
WO2006000902A1 (en) * | 2004-06-25 | 2006-01-05 | Pfizer Products Inc. | Dihydrobenzofuran compounds and uses thereof |
GT200500296A (es) * | 2004-10-21 | 2006-10-02 | Sintesis asimetrica de derivados del dehidrobenzofurano | |
GT200500297A (es) * | 2004-10-21 | 2006-10-27 | Sintesis asimetrica de dehidrobenzofuranos sustituidos | |
JP2008538571A (ja) * | 2005-04-22 | 2008-10-30 | ワイス | ジヒドロベンゾフラン誘導体およびその使用 |
EP1879569A2 (en) * | 2005-04-22 | 2008-01-23 | Wyeth | Therapeutic combinations for the treatment or prevention of psychotic disorders |
CN101203218A (zh) * | 2005-04-22 | 2008-06-18 | 惠氏公司 | 苯并呋喃基链烷胺衍生物和其作为5-ht2c激动剂的用途 |
CA2604759A1 (en) * | 2005-04-22 | 2006-11-02 | Wyeth | Dihydrobenzofuran derivatives and uses thereof |
CA2605587A1 (en) * | 2005-04-22 | 2006-11-02 | Wyeth | Chromane and chromene derivatives and uses thereof |
GT200600164A (es) * | 2005-04-22 | 2007-03-14 | Derivados de dihidrobenzofuranos y usos de los mismos | |
EP1898895A2 (en) * | 2005-04-22 | 2008-03-19 | Wyeth | Treatment of drug abuse |
JP2008538575A (ja) * | 2005-04-22 | 2008-10-30 | ワイス | ベンゾジオキサンおよびベンゾジオキソラン誘導体ならびにそれらの使用 |
TW200722081A (en) * | 2005-04-22 | 2007-06-16 | Wyeth Corp | New therapeutic combinations for the treatment or prevention of depression |
GT200600158A (es) * | 2005-04-22 | 2006-11-28 | Cristales formados de clorhidrato de {[(2r)-7-(2,6-diclorofenil)-5-fluoro-2,3-dihidro-1-benzofurano-2-il]metil}amina |
-
2006
- 2006-04-21 GT GT200600162A patent/GT200600162A/es unknown
- 2006-04-21 EP EP06758493A patent/EP1874292A2/en not_active Withdrawn
- 2006-04-21 CA CA002606064A patent/CA2606064A1/en not_active Abandoned
- 2006-04-21 CN CNA2006800224896A patent/CN101203217A/zh active Pending
- 2006-04-21 JP JP2008508962A patent/JP2008538784A/ja active Pending
- 2006-04-21 MX MX2007013064A patent/MX2007013064A/es not_active Application Discontinuation
- 2006-04-21 US US11/408,323 patent/US20060258712A1/en not_active Abandoned
- 2006-04-21 WO PCT/US2006/015215 patent/WO2006116169A2/en active Application Filing
- 2006-04-21 BR BRPI0609952-1A patent/BRPI0609952A2/pt not_active Application Discontinuation
- 2006-04-21 AU AU2006239941A patent/AU2006239941A1/en not_active Abandoned
- 2006-04-21 TW TW095114309A patent/TW200716106A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2006116169A2 (en) | 2006-11-02 |
CN101203217A (zh) | 2008-06-18 |
TW200716106A (en) | 2007-05-01 |
EP1874292A2 (en) | 2008-01-09 |
US20060258712A1 (en) | 2006-11-16 |
AU2006239941A1 (en) | 2006-11-02 |
MX2007013064A (es) | 2008-01-16 |
CA2606064A1 (en) | 2006-11-02 |
JP2008538784A (ja) | 2008-11-06 |
BRPI0609952A2 (pt) | 2010-05-11 |
WO2006116169A3 (en) | 2006-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200600162A (es) | Metodos para modular la funcion de la vejiga | |
PA8720701A1 (es) | Metodos para modular la funciòn de la vejiga | |
TNSN08400A1 (en) | Organic compounds and their uses | |
BRPI0510107A (pt) | válvula protéica implantável | |
WO2007037849A3 (en) | Compositions and methods for the intraocular transport of therapeutic agents | |
ECSP109852A (es) | Uso de homo y copolímeros para la estabilización de formulaciones de principios activos | |
CL2009001099A1 (es) | Uso de una muteina de interleuquina-2 humana para el tratamiento y/o prevencion de una enfermedad autoinmune. | |
EP3398560B8 (en) | Systems for surgery and stent valves for replacement | |
CL2007003520A1 (es) | Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso para el tratamiento profilactico o terapeutico del cancer. | |
WO2009009173A3 (en) | Klotho-beta for use in treating cancer, liver disorders, gallstones, wasting syndrome and obesity-related diseases | |
CL2007002384A1 (es) | Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis. | |
CL2007003523A1 (es) | Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad de pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso en el tratamiento profilactico o terapeutico del cancer | |
NI201000044A (es) | Bromhidrato de bupropión y aplicaciones terapéuticas | |
ECSP088763A (es) | Nuevas combinaciones terapéuticas para el tratamiento de la depresión | |
WO2006116221A3 (en) | Therapeutic combinations for the treatment or prevention of psychotic disorders | |
EP2083070A4 (en) | MICROORGANISM WITH ABILITY TO COMBAT PLANT DISEASES AND PLANT DISEASES USING THE MICROORGANISM OF COMBATING AGING | |
CL2012002887A1 (es) | Combinación farmacéutica que comprende compuestos derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituida, compuestos derivados de n-(2-arilamino)arilsulfonamida y opcionalmente otros agentes farmacéuticos adicionales; kit faramacéutico; método de tratamiento; y su uso para el tratamiento o la profilaxis del cáncer. | |
MX2008001597A (es) | Formulaciones novedosas que comprenden fenofibrato y una estatina y metodos relacionados de tratamiento. | |
TNSN08496A1 (en) | Aminothiazoles and their uses | |
SV2006002290A (es) | Nonadepsipeptidos acilados ii ref. bhc041327-sv | |
ECSP088761A (es) | Nuevas combinaciones terapéuticas para el tratamiento o la prevención de trastornos psicóticos | |
WO2008033389A3 (en) | Macrocyclic hcv inhibitors and their uses | |
AR064214A1 (es) | Uso de epotilonas en el tratamiento de la osteoporosis y enfermedades relacionadas | |
CL2008002884A1 (es) | Composicion farmaceutica compuesta por meloxicam o calecoxib y alopurinol; composicion farmaceutica; y uso para el control y tratamiento de la gota, la artritis gotosa y otras patologias relacionadas. | |
CL2007003281A1 (es) | Compuesto 1-(4-metilfenil)dihidro-1h-pirrolo[1,2-a]imidazol-2,5-(3h,6h)-diona; composicion farmaceutica; y uso para el tratamiento terapeutico o preventivo de la neurotoxicidad periferica inducida por quimioterapeuticos. |